The short-term benefits of methylphenidate and dexamphetamine in the management of Attention Deficit Hyperactivity Disorder (ADHD) symptoms are well described throughout the literature. Similarly, the short-term side-effects of these stimulant medications are well-documented. However, the long-term benefits and side-effects have been less well studied.
This project uses longitudinal data collected as part of the Western Australian Pregnancy Birth Cohort to examine the long-term social, emotional, school-based, growth, and cardiovascular outcomes associated with the use of stimulant medication in the treatment of ADHD. These outcomes are measured at the age of 14 years.